PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer

著录项

• 来源
  《International Journal of Radiation Oncology, Biology, Physics》 |2017年第5期|共4页
• 作者

  Antonia S. J.; Villegas A.; Daniel D.; Baz D. Vincente; Murakami S.; Hui R.; Yokoi T.; Chiappori A.; Lee K. H.; de Wit M.; Cho B. C.; Bourhaba M.; Quantin X.; Tokito T.; Mekhail T.; Planchard D.; Jiang H.; Huang Y.; Dennis P. A.; Ozguroglu M.;

  展开▼
• 作者单位

  H Lee Moffitt Canc Ctr &

  Res Inst Tampa FL USA;

  Canc Specialists North Florida Jacksonville FL USA;

  Tennessee Oncol Chattanooga TN USA;

  Hosp Univ Virgen Macarena Seville Spain;

  Kanagawa Canc Ctr Yokohama Kanagawa Japan;

  Westmead Hosp Sydney NSW Australia;

  Kansai Med Univ Hosp Hirakata Osaka Japan;

  H Lee Moffitt Canc Ctr &

  Res Inst Tampa FL USA;

  Chungbuk Natl Univ Chungbuk Natl Univ Hosp Coll Med Cheongju South Korea;

  Vivantes Klinikum Neukoelln Berlin Germany;

  Yonsei Univ Yonsei Canc Ctr Coll Med Seoul South Korea;

  Ctr Hosp Univ Liege Liege Belgium;

  CHU Montpellier Montpellier France;

  Kurume Univ Hosp Kurume Fukuoka Japan;

  Florida Hosp Inst Canc Orlando FL USA;

  Gustave Roussy Villejuif France;

  AstraZeneca Gaithersburg MD USA;

  AstraZeneca Gaithersburg MD USA;

  AstraZeneca Gaithersburg MD USA;

  Istanbul Univ Cerrahpasa Med Sch Istanbul Turkey;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 放射医学;
• 关键词